The severity of someone’s illness depends on the microbe that is causing it, their general health and their age.

The tremendous activity in anti-HCV drug development needs to be extended to HCV vaccine development. Continued research activities to provide further insights into the mechanisms of HCV clearance ...

“New generation vaccines need to be rolled out through the National Immunisation Program without further delay. We simply can’t risk not having the best available pneumococcal protection ...

Experts believe three factors may be driving the increase in invasive pneumococcal disease: "The challenge is three-fold," added Professor Richmond. "We're seeing a drop in vaccine coverage alongside ...

Aaron Siri, Robert F. Kennedy Jr.’s personal attorney, has petitioned the Food and Drug Administration to revoke its approval of the hepatitis B and polio vaccines, and block the distribution of ...

Anyone can get pneumococcal disease, but older adults are at higher risk of serious illness or death. The CDC recommends vaccination for adults 50 and older and for other adults who are at higher ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

Dec. 9, 2024 -- The updated COVID vaccines for 2024-2025 are officially here, designed to target the latest variants and offer robust protection — but getting Americans to roll up their sleeves ...

The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due to the high genetic diversity of the virus. A research team has now ...

Indeed, HCV has been identified as one of the globally prioritized endemic pathogens for vaccine research and development in the World Health Organization's "Immunization Agenda 2030." It is among ...

These guidelines lower the recommended age for this pneumococcal pneumonia vaccine from age 65 to 50, covering millions of currently unprotected people. Scientific American spoke with experts ...